where it is sold by Britain’s GSK plc in those areas. Taisho Pharmaceutical will be responsible for the drug’s sales in Japan. Alli will be available only to those 18 years or older.

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.

Pharmaceutical giant GSK and the University of Oxford have teamed up to make a vaccine that targets cells at the pre-cancerous stage. The university has world-leading expertise in the study of pre ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Last week's rumour that GSK was poised to make a bid to acquire IDRx and its experimental targeted therapy for a rare form of rare gastrointestinal cancer was on the money. This morning ...

Teva Pharmaceutical Industries Ltd. ADR-3.78% $21.4B ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...

Prospect’s Alli Linke (23) drives toward the basket as the Knights play Maine South, Park Ridge, Illinois. | Allen Cunningham for Sun Times Allen Cunningham/For the Sun Times Share Prospect ...

After hours: 7:34:23 p.m. EST ...